Corrigendum to S.O. 5635(E) dated 02.11.2018

**Executive Summary** Issued by the National Pharmaceutical Pricing Authority on March 25, 2026, this corrigendum (S.O. 1592(E)) amends a 2018 notification regarding pharmaceutical retail price fixation. The document corrects the manufacturer and marketing company name for a specific entry in the original table. All other notes and provisions from the initial order dated November 2, 2018, remain in full effect. **Key Points / Main Content** **Administrative Information** * **Issuing Authority:** National Pharmaceutical Pricing Authority (NPPA), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers. * **Reference Details:** The document serves as a corrigendum to the original notification S.O. 5635(E) dated November 2, 2018. * **Publication Date:** New Delhi, March 25, 2026. **Specific Amendment** * **Target Entry:** Table Serial Number 7, Column Number 8 of the original notification. * **Name Correction:** The manufacturer and marketing company name is revised to "M/s Sun Pharmaceutical Industries Limited." * **Superseded Name:** This replaces the previous entry, which listed "M/s Pure and Cure Healthcare Pvt. Ltd. and M/s Sun Pharmaceutical Industries Limited." **Provision Continuity** * **Unaltered Content:** All other notes and supplementary contents mentioned in the original 2018 order relating to Serial Number 7 remain unchanged. * **Regulatory Authority:** The notification was published by authority and signed by Bhiva Ram Yadav, Assistant Director. **Impact Analysis** **M/s Sun Pharmaceutical Industries Limited** **Impact** The company is now officially designated as the sole manufacturer and marketing entity for the product listed under Serial Number 7 of the amended pricing table. **Action Required** The company must ensure that its branding and pricing documentation for the specified product align with this corrected official designation and the retail price set in the original 2018 notification. **M/s Pure and Cure Healthcare Pvt. Ltd.** **Impact** The company's name is removed from the official manufacturer and marketing designation for the specific entry mentioned. **Action Required** Update internal records to reflect that they are no longer listed as a joint manufacturer/marketer for this specific regulatory entry. **Regulatory Authorities and Pharmacies** **Impact** Pricing schedules and regulatory databases must be updated to reflect the accurate company name for enforcement and compliance monitoring. **Action Required** Update all administrative and price tracking records to attribute the retail price fixation of the drug at Sl. No. 7 to "M/s Sun Pharmaceutical Industries Limited" exclusively.

Key Entities Referenced